Cargando…
Cancer and Postradiotherapy Cardiotoxicity: How to Face Damage in Women’s Hearts?
Cancer and cardiovascular disease are the two main causes of death worldwide in both men and women. In the past decades, survival rate in cancer patients has substantially improved due to new treatments and developments in radiation therapy (RT). In women, breast cancer (BC) is the leading cause of...
Autores principales: | Peix, Amalia, Perez, Aylen, Barreda, Ana Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291578/ https://www.ncbi.nlm.nih.gov/pubmed/37377450 http://dx.doi.org/10.15420/ecr.2022.36 |
Ejemplares similares
-
Permissive Cardiotoxicity: The Clinical Crucible of Cardio-Oncology
por: Porter, Charles, et al.
Publicado: (2022) -
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
por: de Boer, Rudolf A., et al.
Publicado: (2020) -
Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer
por: Ganatra, Sarju, et al.
Publicado: (2022) -
Increased resting heart rate and prognosis in treatment‐naïve unselected cancer patients: results from a prospective observational study
por: Anker, Markus S., et al.
Publicado: (2020) -
The Role of Single-Cell Profiling and Deep Immunophenotyping in Understanding Immune Therapy Cardiotoxicity
por: Huang, Yuhsin Vivian, et al.
Publicado: (2022)